Emergen Research Logo Driven by Advances in Gene Sequencing and Growing Need for Precision MedicineVANCOUVER, BRITISH COLUMBIA, CA ...

NewBiologix, a next-generation biotechnology company pioneering the future of recombinant adeno-associated virus (rAAV) production through a unique DNA-based platform built on stable cell line ...

FMS-like tyrosine kinase 3 (FLT3) mutations represent some of the most pivotal genetic alterations in acute myeloid leukemia (AML), influencing ...

The Southeast Asia molecular diagnostics market is set to grow from USD 528.3 million in 2024 to USD 891.9 million by 2031, at a 7.8% CAGR. Key drivers include a rising elderly population, increased ...

Mass photometry enables rapid, purification-free quantification of rAAV vectors, offering a faster solution for gene therapy manufacturing.

Overall survival (OS) in BRCA -mutated breast cancer improved significantly with the addition of olaparib (Lynparza) to ...

New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both ...

The FDA approved using gene-editing technology that can create pigs resistant to the highly contagious, and costly, porcine ...

A multi-institutional collaboration of synthetic biology research centers in China has developed a genetically engineered ...

Innovation of the Year for a product or service The rise of gene therapy has placed adeno-associated virus (AAV) vectors at ...

NewBiologix utilises technologies that combine multidimensional digital polymerase chain reaction (PCR) and third-generation ...

Digital PCR to simultaneously detect SMN1 gene defects and the number of SMN2 copies to diagnose SMA matches standard methods ...